Traditional Chinese medicine treatment for migraine with aura related to patent foramen ovale by resolving constraint and harmonizing the spleen and stomach: a case report
Case Reports|更新时间:2023-12-08
|
Traditional Chinese medicine treatment for migraine with aura related to patent foramen ovale by resolving constraint and harmonizing the spleen and stomach: a case report
Modern Chinese Clinical MedicineVol. 30, Issue 6, Pages: 113-116(2023)
WU Lianghui, LIN Keyi, QIU Yuhui. Traditional Chinese medicine treatment for migraine with aura related to patent foramen ovale by resolving constraint and harmonizing the spleen and stomach: a case report. [J]. Modern Chinese Clinical Medicine 30(6):113-116(2023)
DOI:
WU Lianghui, LIN Keyi, QIU Yuhui. Traditional Chinese medicine treatment for migraine with aura related to patent foramen ovale by resolving constraint and harmonizing the spleen and stomach: a case report. [J]. Modern Chinese Clinical Medicine 30(6):113-116(2023) DOI: 10.3969/j.issn.2095-6606.2023.06.025.
Traditional Chinese medicine treatment for migraine with aura related to patent foramen ovale by resolving constraint and harmonizing the spleen and stomach: a case report
Patent foramen ovale (PFO) is a congenital cardiac anomaly caused by incomplete fusion of the atrial septum after birth. PFO is closely associated with the development of migraine with aura (MA). The pathogenesis of PFO-induced migraine is still unclear
and the treatment is based on PFO closure and pain relief treatment during attacks. One case of PFO-associated MA was treated with TCM herbal medicine by resolving constraint and harmonizing the spleen and stomach
which achieved satisfactory efficacy
and the headache and aura did not reoccur in 1 year of follow-up
suggesting that organic changes are not the single pathogenetic factor of the disease
and that medications to improve the patient’s function or susceptibility can be a treatment option for the disease. This could provide some ideas for TCM treatment of the disease.
关键词
卵圆孔未闭先兆性偏头痛解郁和中法中医药
Keywords
patent foramen ovalemigraine with auraresolving constraint and harmonizing the spleen and stomachtraditional Chinese medicine
references
WANG S B,LIU K D,YANG Y,et al. Prevalence and extent of right-to-left shunt on contrast-enhanced transcranial Doppler in Chinese patients with migraine in a multicentre case-control study[J]. Cephalalgia,2018, 38(4): 690-696.
LIU K,WANG B Z,HAO Y,et al. The correlation between migraine and patent foramen ovale[J/OL]. Front Neurol,2020, 11: 543485[2022-09-23]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736411/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736411/.
ZHANG Q Q,LU J J,YAN M Y,et al. The efficacy of percutaneous patent foramen ovale closure on migraine: a meta-analysis of randomized controlled trials and observational studies[J/OL]. Biomed Res Int,2021, 2021: 6643266[2022-09-23]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954613/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954613/.
GUO Y,SHI Y,ZHU D,et al.Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale[J].J Investig Med,2020, 68(7): 1250-1255.
KHASIYEV F,ARSAVA E M,TOPCUOGLU M A.Cerebral vasomotor reactivity in migraine: effect of patent foramen ovale and aerogenic microembolism[J].Neurol Res,2020, 42(9): 795-804.
ZHAO Q,LIU R,ZHOU J,et al. Prevalence and grade of RLS in migraine: A prospective study of 251 migraineurs by synchronous test of c-TTE and c-TCD[J/OL]. Medicine (baltimore),2021, 100(4): e24175[2022-09-23]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850732/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850732/.
DOWSON A,MULLEN M J,PEATFIELD R,et al. Migraine Intervention With STARFlex Technology(MIST) trial: a prospective,multicenter,double-blind,sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache[J]. Circulation,2008, 117(11): 1397-1404.
MATTLE H P,EVERS S,HILDICK-SMITH D,et al. Percutaneous closure of patent foramen ovale in migraine with aura,a randomized controlled trial[J]. Eur Heart J,2016, 37(26): 2029-2036.
TOBIS J M,CHARLES A,SILBERSTEIN S D,et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial[J].J Am Coll Cardiol,2017, 70(22): 2766-2774.
PRISTIPINO C,GERMONPRÉ P,TONI D,et al. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness,migraine,arterial deoxygenation syndromes and select high-risk clinical conditions[J]. EuroIntervention,2021, 17(5): e367-e375.
HEADACHE CLASSIFICATION SUBCOMMITTEE OD THE INTERNATIONAL HEADACHE SOCIETY.The international classification of headache disorders: 3rd edition[J]. Cephalalgia,2018, 38(1): 122-125.